Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31382 ↗Kurz gefasst
Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Moras Patrizio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fetal, Neonatal and Cardiovascular Sciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Coronary Aneurysm, Tissue Plasminogen Activator, Fibrinolytic Agents. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kawasaki Disease (KD) is a systemic vasculitis that can lead to coronary artery aneurysms (CAA) in up to 10% of treated cases, significantly increasing the risk of thrombosis and acute myocardial infarction (AMI). While thrombolytic therapy is commonly used in adult coronary syndromes, its application in pediatric KD remains poorly studied. We report a 9‐month‐old infant with KD and giant CAA complicated by a subocclusive thrombus in the left anterior descending artery (LAD). Initial systemic intravenous thrombolysis (IVCT) with alteplase failed to prevent progression to ST‐elevation myocardial infarction (STEMI). Intracoronary thrombolysis (ICT) was subsequently performed, achieving partial reperfusion without complications. At 18 months of follow‐up, the patient remained asymptomatic with stable left ventricular dysfunction. This single case illustrates the potential feasibility of combining ICT and IVCT in managing coronary thrombosis in pediatric KD. However, as a single observation, these findings cannot be generalized, and the approach requires further investigation. Robust multicenter studies are necessary to establish the safety, efficacy, and optimal use of thrombolytic therapy in pediatric KD patients with coronary thrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Fetal, Neonatal and Cardiovascular Sciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Moras Patrizio, Rebonato Micol
Zitieren
APA
Patrizio, M., Mara, P., Micol, R., & Gianfranco, B. (2025). Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31382
Vancouver
Patrizio M, Mara P, Micol R, Gianfranco B. Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31382
BibTeX
@article{Patrizio2025,
author = {Patrizio, Moras and Mara, Pilati and Micol, Rebonato and Gianfranco, Butera},
title = {Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31382}
}
EUVIMED